RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00059887.xml
CC BY 4.0 · Brazilian Journal of Oncology 2025; 21
DOI: 10.1055/s-0045-1808002
DOI: 10.1055/s-0045-1808002
THORACIC TUMORS
1809
POSTER PRESENTATION
Impact of gefitinib combined with chemotherapy in lung cancer patients with classic EGFR mutations: a real-world study at Barretos Cancer Hospital
Publikationsverlauf
Artikel online veröffentlicht:
06. Mai 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil
Bibliographical Record
Isabela Fernandes Rivelli Cardoso, Gabriela Panini Batagelo, Rodrigo de Oliveira Cavagna, Josiane Mourão Dias, Amelia Gontijo Velozo de Melo, Carlos Eduardo Baston Silva, Gustavo Dix Junqueira Pinto, Augusto Perazzolo Antoniazzi, Leticia Ferro Leal, Flavio Augusto Ferreira da Silva. Impact of gefitinib combined with chemotherapy in lung cancer patients with classic EGFR mutations: a real-world study at Barretos Cancer Hospital. Brazilian Journal of Oncology 2025; 21.
DOI: 10.1055/s-0045-1808002
Isabela Fernandes Rivelli Cardoso, Gabriela Panini Batagelo, Rodrigo de Oliveira Cavagna, Josiane Mourão Dias, Amelia Gontijo Velozo de Melo, Carlos Eduardo Baston Silva, Gustavo Dix Junqueira Pinto, Augusto Perazzolo Antoniazzi, Leticia Ferro Leal, Flavio Augusto Ferreira da Silva. Impact of gefitinib combined with chemotherapy in lung cancer patients with classic EGFR mutations: a real-world study at Barretos Cancer Hospital. Brazilian Journal of Oncology 2025; 21.
DOI: 10.1055/s-0045-1808002